Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

NATIONAL MULTIPLE SCLEROSIS SOCIETY

Filed by NATIONAL MULTIPLE SCLEROSIS SOCIETY.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 21, 2025
Income
Not reported
Expenses
$83,979.00
Filing UUID
e1afc942-81d5-45f3-a054-4b004da9f3fc
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Supporting the following funding levels in FY25 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out in the last Continuing Resolution. Specifically $22 million for the MS Research Program and $6.54 Million for Veterans Affairs Centers of Excellence.

Literal federal measure citations: H.R.1968, H.Con.Res.14

HCR · Health Issues

S. 925 - Credit for Caring Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2320 - The Mobility Means Freedom Tax Credit Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Commented and proposed recommendations on FDA's Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products as well as FDA's Artificial Intelligence-Enabled Device Software Functions.

Literal federal measure citations: S. 925, H.R. 2036, H.R. 2320, S. 830, H.R. 2560, H.R.1968, H.Con.Res.14

MMM · Medicare/Medicaid

H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Joined with coalition partners to request CMS to expand coverage for anti-obesity medications. In January commented on CMS's Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly. In April provided recommendations on CMS's Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability.

Literal federal measure citations: H.R.1968, H.Con.Res.14

MED · Medical/Disease Research/Clinical Labs

H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.

Literal federal measure citations: H.R.1968, H.Con.Res.14

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.